SK hynix Inc. has completed the construction of its M16 chip fabrication plant at its main production base in Icheon to expand its presence in the memory sector.
The M16 has extreme ultraviolet (EUV) lithography equipment that allows SK hynix to manufacture chips with finer circuit patterns, such as the fourth-generation 10-nanometer DRAM products, which it is set to mass-produce beginning June.
SK hynix CEO Lee Seok-hee described M16 as a complex manufacturing plant equipped with cutting-edge infrastructures, such as dedicated space for EUV equipment and advanced pollution reduction facilities.
It took over two years of construction for SK Hynix, South Korea's No. 2 chipmaker and the world's second-largest DRAM maker, to complete the plant.
SK hyinx invested 20 trillion won, including manufacturing equipment, in the facility. Of that amount, 3.5 trillion won went to the construction of the plant.
The new factory is the company's biggest, measuring 163 meters wide, 336 meters long, and 105 meters high, which is equivalent to a 37-story building.
According to SK Group Chairman Chey Tae-won, they were apprehensive when they began construction two years ago due to the downturn of the semiconductor memory industry.
He added that since the industry anticipates upcoming positive market conditions, they made the bold decision to proceed with the project.
The M16, says Cey, signals the "beginning point" of Yongin Semiconductor Cluster, where SK hynix plans to invest a total of 122 trillion won for a chip manufacturing industrial complex.
He added that the M16 would contribute to the ESG management as well as create economic value.


Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 



